Bausch Health (XSWX:VRX) 3-Year EBITDA Growth Rate

: -2.60% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

Bausch Health's EBITDA per Share for the three months ended in Dec. 2023 was CHF1.67.

During the past 12 months, Bausch Health's average EBITDA Per Share Growth Rate was -20.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -2.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 32.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -1.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Bausch Health was 253.00% per year. The lowest was -55.80% per year. And the median was 14.25% per year.

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bausch Health 3-Year EBITDA Growth Rate Distribution

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Bausch Health's 3-Year EBITDA Growth Rate falls into.

Bausch Health 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Bausch Health (XSWX:VRX) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Bausch Health 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Bausch Health's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch Health (XSWX:VRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (XSWX:VRX) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

BHC:USA BVF:Germany BHC:Canada

Address

2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8

Website

https://www.bauschhealth.com

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health (XSWX:VRX) Headlines

No Headlines